62 related articles for article (PubMed ID: 9069579)
1. Selection of retrovirally transduced cells to enhance the efficiency of gene therapy.
Medin JA; Karlsson S
Proc Assoc Am Physicians; 1997 Mar; 109(2):111-9. PubMed ID: 9069579
[TBL] [Abstract][Full Text] [Related]
2. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells.
Allay JA; Galipeau J; Blakley RL; Sorrentino BP
Stem Cells; 1998; 16 Suppl 1():223-33. PubMed ID: 11012166
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
[TBL] [Abstract][Full Text] [Related]
4. Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene.
Capiaux GM; Budak-Alpdogan T; Alpdogan O; Bornmann W; Takebe N; Banerjee D; Maley F; Bertino JR
Cancer Gene Ther; 2004 Dec; 11(12):767-73. PubMed ID: 15359285
[TBL] [Abstract][Full Text] [Related]
5. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
[TBL] [Abstract][Full Text] [Related]
6. In vivo selection of retrovirally transduced hematopoietic stem cells.
Allay JA; Persons DA; Galipeau J; Riberdy JM; Ashmun RA; Blakley RL; Sorrentino BP
Nat Med; 1998 Oct; 4(10):1136-43. PubMed ID: 9771746
[TBL] [Abstract][Full Text] [Related]
7. Transduction of fibroblasts and CD34+ progenitors using a selectable retroviral vector containing cDNAs encoding arylsulfatase A and CD24.
Tsutsudaasano A; Migita M; Takahashi K; Shimada T
J Hum Genet; 2000; 45(1):18-23. PubMed ID: 10697958
[TBL] [Abstract][Full Text] [Related]
8. Long-term tracking of murine hematopoietic cells transduced with a bicistronic retrovirus containing CD24 and EGFP genes.
Kume A; Xu R; Ueda Y; Urabe M; Ozawa K
Gene Ther; 2000 Jul; 7(14):1193-9. PubMed ID: 10918487
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.
Wendtner CM; Nolte A; Mangold E; Buhmann R; Maass G; Chiorini JA; Winnacker EL; Emmerich B; Kotin RM; Hallek M
Gene Ther; 1997 Jul; 4(7):726-35. PubMed ID: 9282174
[TBL] [Abstract][Full Text] [Related]
10. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
11. Induction of T cell tolerance to a protein expressed in the cytoplasm through retroviral-mediated gene transfer.
Tian C; Bagley J; Kaye J; Iacomini J
J Gene Med; 2003 May; 5(5):359-65. PubMed ID: 12731084
[TBL] [Abstract][Full Text] [Related]
12. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
Havenga M; Valerio D; Hoogerbrugge P; Es H
Gene Ther; 1999 Oct; 6(10):1661-9. PubMed ID: 10516714
[TBL] [Abstract][Full Text] [Related]
13. Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice.
Licht T; Goldenberg SK; Vieira WD; Gottesman MM; Pastan I
Gene Ther; 2000 Feb; 7(4):348-58. PubMed ID: 10694816
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors.
Tian C; Bagley J; Forman D; Iacomini J
Gene Ther; 2006 Apr; 13(7):652-8. PubMed ID: 16341058
[TBL] [Abstract][Full Text] [Related]
15. Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase.
Belzile JP; Karatzas A; Shiu HY; Létourneau S; Palerme JS; Cournoyer D
Cancer Gene Ther; 2003 Aug; 10(8):637-46. PubMed ID: 12872145
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
Mineishi S; Nakahara S; Takebe N; Banerjee D; Zhao SC; Bertino JR
Gene Ther; 1997 Jun; 4(6):570-6. PubMed ID: 9231073
[TBL] [Abstract][Full Text] [Related]
17. Abrogation of TGF-beta activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency.
Yu J; Soma T; Hanazono Y; Dunbar CE
Gene Ther; 1998 Sep; 5(9):1265-71. PubMed ID: 9930329
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate selectable retroviral vectors for Gaucher disease.
Havenga MJ; Werner AB; Valerio D; van Es HH
Gene Ther; 1998 Oct; 5(10):1379-88. PubMed ID: 9930344
[TBL] [Abstract][Full Text] [Related]
19. Use of protamine to augment adenovirus-mediated cancer gene therapy.
Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
[TBL] [Abstract][Full Text] [Related]
20. Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells.
McCowage GB; Phillips KL; Gentry TL; Hull S; Kurtzberg J; Gilboa E; Smith C
Exp Hematol; 1998 Apr; 26(4):288-98. PubMed ID: 9546311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
